Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of use

RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of use

US Patent 12442002 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmac2025
5′-cyclo-phosphonate modified nucleotides2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic2025
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
Alpha-v beta-6 integrin ligands and uses thereof2024
Alpha-v beta-6 integrin ligands and uses thereof2024
Targeting ligands for therapeutic compounds2024